Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial for COVID-19
Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has achieved full patient enrollment...
NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits EUA Application to US FDA...
NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with...
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the...
Bharat Biotechs Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for...
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat...
Cryoport and LabConnectPartner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical...
LabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an...
CytoDyn and AEIH to begin trials of leronlimab in severe Covid-19
This development is part of CytoDyn’s agreement to collaborate with AEIH to carry out the...
Eiger to add Peginterferon Lambda to Covid-19 trial in Brazil
Eiger BioPharmaceuticals has said that its investigational agent, Peginterferon Lambda, will be added to the...
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced initial data...
Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet...
